Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph S Janicki

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
Expert Opinion on Therapeutic Targets|June 18, 2009
Targeting the Nrf2 pathway against cardiovascular diseaseJinqing Li, Tomonaga Ichikawa, Joseph S Janicki, et al.
Heart, Lung & Circulation|April 4, 2015
Differential Effects of Prevention and Reversal Treatment with Lisinopril on Left Ventricular Remodelling in a Rat Model of Heart FailureGregory L Brower, Scott P Levick, Joseph S Janicki
American Journal of Physiology. Heart and Circulatory Physiology|May 11, 2002
Cardiac mast cell-mediated activation of gelatinase and alteration of ventricular diastolic functionAmanda L Chancey, Gregory L Brower, Joseph S Janicki
Molecular and Cellular Biochemistry|October 25, 2003
Gender mediated cardiac protection from adverse ventricular remodeling is abolished by ovariectomyGregory L Brower, Jason D Gardner, Joseph S Janicki
The American Journal of Pathology|July 24, 2010
Temporal evaluation of cardiac myocyte hypertrophy and hyperplasia in male rats secondary to chronic volume overloadYan Du, Eric Plante, Joseph S Janicki, et al.
IJC Metabolic & Endocrine|January 2, 2016
THE AUTOCRINE ROLE OF TRYPTASE IN PRESSURE OVERLOAD-INDUCED MAST CELL ACTIVATION, CHYMASE RELEASE AND CARDIAC FIBROSISJianping Li, Shaiban Jubair, Scott P Levick, et al.
American Journal of Physiology. Heart and Circulatory Physiology|December 14, 2011
Prevention of adverse cardiac remodeling to volume overload in female rats is the result of an estrogen-altered mast cell phenotypeHong Lu, Giselle C Meléndez, Scott P Levick, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 12, 2009
ETA selective receptor antagonism prevents ventricular remodeling in volume-overloaded ratsDavid B Murray, Ronald McMillan, Gregory L Brower, et al.
Journal of Inflammation Research|September 25, 2013
Estrogen modulates the influence of cardiac inflammatory cells on function of cardiac fibroblastsJennifer L McLarty, Jianping Li, Scott P Levick, et al.
Current Drug Targets|October 25, 2014
CYLD-mediated signaling and diseasesBryan J Mathis, Yimu Lai, Chen Qu, et al.
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
Expert Opinion on Therapeutic Targets|June 18, 2009
Targeting the Nrf2 pathway against cardiovascular diseaseJinqing Li, Tomonaga Ichikawa, Joseph S Janicki, et al.
Heart, Lung & Circulation|April 4, 2015
Differential Effects of Prevention and Reversal Treatment with Lisinopril on Left Ventricular Remodelling in a Rat Model of Heart FailureGregory L Brower, Scott P Levick, Joseph S Janicki
American Journal of Physiology. Heart and Circulatory Physiology|May 11, 2002
Cardiac mast cell-mediated activation of gelatinase and alteration of ventricular diastolic functionAmanda L Chancey, Gregory L Brower, Joseph S Janicki
Molecular and Cellular Biochemistry|October 25, 2003
Gender mediated cardiac protection from adverse ventricular remodeling is abolished by ovariectomyGregory L Brower, Jason D Gardner, Joseph S Janicki
The American Journal of Pathology|July 24, 2010
Temporal evaluation of cardiac myocyte hypertrophy and hyperplasia in male rats secondary to chronic volume overloadYan Du, Eric Plante, Joseph S Janicki, et al.
IJC Metabolic & Endocrine|January 2, 2016
THE AUTOCRINE ROLE OF TRYPTASE IN PRESSURE OVERLOAD-INDUCED MAST CELL ACTIVATION, CHYMASE RELEASE AND CARDIAC FIBROSISJianping Li, Shaiban Jubair, Scott P Levick, et al.
American Journal of Physiology. Heart and Circulatory Physiology|December 14, 2011
Prevention of adverse cardiac remodeling to volume overload in female rats is the result of an estrogen-altered mast cell phenotypeHong Lu, Giselle C Meléndez, Scott P Levick, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 12, 2009
ETA selective receptor antagonism prevents ventricular remodeling in volume-overloaded ratsDavid B Murray, Ronald McMillan, Gregory L Brower, et al.
Journal of Inflammation Research|September 25, 2013
Estrogen modulates the influence of cardiac inflammatory cells on function of cardiac fibroblastsJennifer L McLarty, Jianping Li, Scott P Levick, et al.
Current Drug Targets|October 25, 2014
CYLD-mediated signaling and diseasesBryan J Mathis, Yimu Lai, Chen Qu, et al.
Pageof 8